行情

MTP

MTP

Midatech Pharma
NASDAQ

实时行情|Nasdaq Last Sale

0.6101
-0.0098
-1.58%
已收盘, 16:00 02/20 EST
开盘
0.6100
昨收
0.6200
最高
0.6200
最低
0.6100
成交量
7.99万
成交额
--
52周最高
10.90
52周最低
0.5400
市值
--
市盈率(TTM)
-5.3006
分时
5日
1月
3月
1年
5年

MTP 新闻

  • 《消费者报告》首次将特斯拉Model 3列为"首选车型"
  • 新浪美股.4小时前
  • 低利率的大背景下 市政债券或成“新贵”
  • 新浪财经-自媒体综合.5小时前
  • 巴以双方解除农产品贸易禁令
  • 新华网.6小时前
  • 联储二号人物给交易员"泼冷水" 这次市场共识又错了?
  • FX168.6小时前

更多

所属板块

生物技术和医学研究
+0.10%
制药与医学研究
-0.40%

热门股票

名称
价格
涨跌幅

MTP 简况

Midatech Pharma PLC is an early-stage biopharmaceutical company that focuses on commercializing and developing products in oncology and other therapeutic areas. The Company's segments include Pipeline Research and Development, and Commercial. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms. The Commercial segment distributes and sells the commercial products. Its products include Zuplenz, Gelclair, Oravig and Soltamox. Zuplenz is an oral soluble film indicated for moderately emetogenic chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV). Gelclair is a product indicated for the management and relief of pain due to oral mucositis. Oravig is an orally dissolving buccal tablet approved for oral thrush. Soltamox is an oral liquid solution of tamoxifen citrate for the prevention of breast cancer.
展开

Webull提供Midatech Pharma PLC-ADR的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。